Body fat distribution and insulin resistance

Pavankumar Patel, Nicola Abate, Pavankumar Patel, Nicola Abate

Abstract

The burden of obesity has increased globally over the last few decades and its association with insulin resistance and related cardio-metabolic problems have adversely affected our ability to reduce population morbidity and mortality. Traditionally, adipose tissue in the visceral fat depot has been considered a major culprit in the development of insulin resistance. However, there is a growing body of evidence supporting the role of subcutaneous truncal/abdominal adipose tissue in the development of insulin resistance. There are significant differences in the functional characteristics of subcutaneous abdominal/truncal vs. intraabdominal vs. gluteo-femoral fat depots. More recently, mounting evidence has been supporting the role of adipose tissue function in the development of metabolic complications independent of adipose tissue volume or distribution. Decreased capacity for adipocyte differentiation and angiogenesis along with adipocyte hypertrophy can trigger a vicious cycle of inflammation leading to subcutaneous adipose tissue dysfunction and ectopic fat deposition. Therapeutic lifestyle change continues to be the most important intervention in clinical practice to improve adipose tissue function and avoid development of insulin resistance and related cardio-metabolic complications.

References

    1. International Association for the Study of Obesity. [(accessed on 9 February 2013)]. Available online:
    1. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303:235–241. doi: 10.1001/jama.2009.2014.
    1. Ogden C.L., Carroll M.D., Curtin L.R., Lamb M.M., Flegal K.M. Prevalence of high body mass index in US children and adolescents, 2007–22008. JAMA. 2010;303:242–249. doi: 10.1001/jama.2009.2012.
    1. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., Eckel R.H., American Heart Association. Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918. doi: 10.1161/CIRCULATIONAHA.106.171016.
    1. Després J.P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., Rodés-Cabau J., Bertrand O.F., Poirier P. Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 2008;28:1039–1049. doi: 10.1161/ATVBAHA.107.159228.
    1. Primeau V., Coderre L., Karelis A.D., Brochu M., Lavoie M.E., Messier V., Sladek R., Rabasa-Lhoret R. Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. (Lond.) 2011;35:971–981.
    1. Ortega F.B., Lee D.C., Katzmarzyk P.T., Ruiz J.R., Sui X., Church T.S., Blair S.N. The intriguing metabolically healthy but obese phenotype: Cardiovascular prognosis and role of fitness. Eur. Heart J. 2013;34:389–397.
    1. Romero-Corral A., Somers V.K., Sierra-Johnson J., Korenfeld Y., Boarin S., Korinek J., Jensen M.D., Parati G., Lopez-Jimenez F. Normal weight obesity: A risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur. Heart J. 2010;31:737–746.
    1. Main M.L., Rao S.C., O’Keefe J.H. Trends in obesity and extreme obesity among US adults. JAMA. 2010;303:1695–1696.
    1. Garg A. Regional adiposity and insulin resistance. J. Clin. Endocrinol. Metab. 2004;89:4206–4210. doi: 10.1210/jc.2004-0631.
    1. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J. (Clin. Res. Ed.) 1984;289:1257–1261.
    1. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L., INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937–952.
    1. Canoy D., Boekholdt S.M., Wareham N., Luben R., Welch A., Bingham S., Buchan I., Day N., Khaw K.T. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation into Cancer and Nutrition in Norfolk cohort: A population-based prospective study. Circulation. 2007;116:2933–2943.
    1. Ohira T., Shahar E., Chambless L.E., Rosamond W.D., Mosley T.H., Jr., Folsom A.R. Risk factors for ischemic stroke subtypes: The atherosclerosis risk in communities study. Stroke. 2006;37:2493–2498.
    1. Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., Kotani K., Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes. Res. 1995;2:187S–194S.
    1. Fujimoto W.Y., Abbate S.L., Kahn S.E., Hokanson J.E., Brunzell J.D. The visceral adiposity syndrome in Japanese-American men. Obes. Res. 1994;2:364–371.
    1. Banerji M.A., Faridi N., Atluri R., Chaiken R.L., Lebovitz H.E. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J. Clin. Endocrinol. Metab. 1999;84:137–144.
    1. McLaughlin T., Lamendola C., Liu A., Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J. Clin. Endocrinol. Metab. 2011;96:E1756–E1760.
    1. Garg A. The Role of Body Fat Distribution in Insulin Resistance. In: Reaven G.M., Laws A., editors. Insulin Resistance: The Metabolic Syndrome X. Humana Press; Totowa, NJ, USA: 1999. pp. 83–96.
    1. Jensen M.D., Johnson C.M. Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. Metabolism. 1996;45:662–666.
    1. Abate N., Garg A., Peshock R.M., Stray-Gundersen J., Grundy S.M. Relationship of generalized and regional adiposity to insulin sensitivity in men. J. Clin. Invest. 1995;96:88–98.
    1. Abate N., Garg A., Peshock R.M., Stray-Gundersen J., Adams-Huet B., Grundy S.M. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes. 1996;45:1684–1693.
    1. Goodpaster B.H., Thaete F.L., Simoneau J.A., Kelley D.E. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 1997;46:1579–1585.
    1. Ferreira I., Henry R.M., Twisk J.W., van Mechelen W., Kemper H.C., Stehouwer C.D. The metabolicsyndrome, cardiopulmonaryfitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: The Amsterdam growth and health longitudinal study. Arch. Intern. Med. 2005;165:875–882.
    1. Ross R., Shaw K.D., Rissanen J., Martel Y., De Guise J., Avruch L. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: Anthropometric relationships. Am. J. Clin. Nutr. 1994;59:1277–1285.
    1. Ross R., Shaw K.D., Martel Y., De Guise J., Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am. J. Clin. Nutr. 1993;57:470–475.
    1. Ross R., Rissanen J. Mobilization of visceral and subcutaneous adipose tissue in response to energy restriction and exercise. Am. J. Clin. Nutr. 1994;60:695–703.
    1. Apovian C.M., Bigornia S., Mott M., Meyers M.R., Ulloor J., Gagua M., McDonnell M., Hess D., Joseph L., Gokce N. Adiposemacrophageinfiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler. Thromb. Vasc. Biol. 2008;28:1654–1659.
    1. Bremer A.A., Devaraj S., Afify A., Jialal I. Adipose tissuedysregulation in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 2011;96:E1782–E1788.
    1. Lê K.A., Mahurkar S., Alderete T.L., Hasson R.E., Adam T.C., Kim J.S., Beale E., Xie C., Greenberg A.S., Allayee H., Goran M.I. Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-κB stress pathway. Diabetes. 2011;60:2802–2809.
    1. Van Tienen F.H., van der Kallen C.J., Lindsey P.J., Wanders R.J., van Greevenbroek M.M., Smeets H.J. Preadipocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity. Int. J. Obes. (Lond.) 2011;35:1154–1164.
    1. Goedecke J.H., Evans J., Keswell D., Stimson R.H., Livingstone D.E., Hayes P., Adams K., Dave J.A., Victor H., Levitt N.S., et al. Reducedgluteal expression of adipogenic and lipogenic genes in Black South African women is associated with obesity-related insulin resistance. J. Clin. Endocrinol. Metab. 2011;96:E2029–E2033.
    1. Lundgren M., Svensson M., Lindmark S., Renstrom F., Ruge T., Eriksson J.W. Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’. Diabetologia. 2007;50:625–633.
    1. Chandalia M., Lin P., Seenivasan T., Livingston E.H., Snell P.G., Grundy S.M., Abate N. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One. 2007;2:e812.
    1. Chandalia M., Cabo-Chan A.V., Jr., Devaraj S., Jialal I., Grundy S.M., Abate N. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J. Clin. Endocrinol. Metab. 2003;88:3773–3776.
    1. Gealekman O., Guseva N., Hartigan C., Apotheker S., Gorgoglione M., Gurav K., Tran K.V., Straubhaar J., Nicoloro S., Czech M.P., et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation. 2011;123:186–194.
    1. Snijder M.B., Visser M., Dekker J.M., Goodpaster B.H., Harris T.B., Kritchevsky S.B., De Rekeneire N., Kanaya A.M., Newman A.B., Tylavsky F.A., et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia. 2005;48:301–308.
    1. Snijder M.B., Zimmet P.Z., Visser M., Dekker J.M., Seidell J.C., Shaw J.E. Independent and oppositeassociations of waist and hipcircumferences with diabetes, hypertension and dyslipidemia: The AusDiab Study. Int. J. Obes. Relat. Metab. Disord. 2004;28:402–409.
    1. Seidell J.C., Pérusse L., Després J.P., Bouchard C. Waist and hipcircumferences have independent and oppositeeffects on cardiovascular diseaserisk factors: The QuebecFamilyStudy. Am. J. Clin. Nutr. 2001;74:315–321.
    1. Snel M., Jonker J.T., Schoones J., Lamb H., de Roos A., Pijl H., Smit J.W., Meinders A.E., Jazet I.M. Ectopicfat and insulin resistance: Pathophysiology and effect of diet and lifestyle interventions. Int. J. Endocrinol. 2012;2012:983814.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다